Company intelligence / Profile preview

IMEGEN

Paterna (Valencia), Valencian Community, Spain

Ownership: Private
Employees: ~50
Development stage: Other

Overview

IMEGEN is a commercial genetic diagnostics laboratory providing a wide portfolio of clinical genetic and genomic tests across prenatal, pediatric, and adult medicine, and is now part of the Health in Code group formed by integrating Imegen, Genycell Biotech, and Health in Code in 2019.[2][3]

Therapeutic areas: Rare Diseases
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on IMEGEN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMEGEN.

Explore the full profile